Clinical Trial Update: Study of SAB-176 in Healthy Adult Participants [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for SAB-176 in healthy adults with Influenza A H1N1; the study has completed enrollment and results have been posted (results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza H1n1

Drugs mentioned

• SAB-176

Snippet

Sponsor: SAb Biotherapeutics, Inc. | Conditions: Influenza A H1N1 | Phase 2 | Status: COMPLETED | Results posted: 2025-01-22